BIPROGY to absorb Emellience Partners, launch new investment fund

BIPROGY Inc. announced a simplified absorption-type merger of its wholly owned subsidiary, Emellience Partners Inc., effective April 1, 2026. Before the merger, BIPROGY will waive ¥1,500 million in short-term loans and other debts owed by Emellience Partners, addressing its insolvency. This move aims to accelerate business expansion by leveraging Emellience Partners' intellectual property and talent for growth investments, aligning with BIPROGY's Management Policies (2024-2026).

Concurrently, BIPROGY is establishing the BCF1 Limited Partnership, a subsidiary aimed at strategic investments in startup firms, with an establishment date planned for January 14, 2026. The company will invest up to a maximum of ¥4.95 billion as a limited partner in the fund, which will be managed by its wholly owned subsidiary, Canal Ventures, Ltd. This initiative is designed to foster new business opportunities and support the BIPROGY Group's sustained growth towards its "Vision 2030."

These strategic actions are expected to have an insignificant impact on BIPROGY’s consolidated financial results for the current fiscal year.